Filtered Search Results
R&D Systems™ Recombinant Human EGF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | EGF |
| Source | E. coli-derived human EGF protein Asn971-Arg1023, with an N-terminal Met |
| Name | EGF |
| Accession Number | P01133 |
| Gene ID (Entrez) | 1950 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 500 μg/mL in sterile PBS. |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human TGF-beta 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Conjugate | Unconjugated |
|---|---|
| Gene Alias | CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1 |
| Gene ID (Entrez) | 7040 |
| Structural Form | Disulfide-linked homodimer |
| Recombinant | Recombinant |
| Name | TGF-beta 1 |
R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (146 aa) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Accession Number | NP_001997.5 |
|---|---|
| Conjugate | Unconjugated |
| Gene Alias | Basic fibroblast growth factor, basic fibroblast growth factor bFGF, bFGF, FGF2, FGF-2, FGFBprostatropin, fibroblast growth factor 2 (basic), HBGF-2, heparin-binding growth factor 2, Prostatropin |
| Molecular Weight (g/mol) | M.W.-observed: 16-19 kDa, under reducing conditions., M.W.-theroretical: 17 kDa |
| Gene ID (Entrez) | 2247 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in HEPES and Sodium Sulfate with Trehalose. |
| Reconstitution | Reconstitute 10 μg size at 100 μg/mL in sterile deionized water. Reconstitute all the other sizes at 500 μg/mL in sterile deionized water. |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | FGF basic/FGF2/bFGF |
| Source | E. coli-derived human FGF basic/FGF2/bFGF protein Ala135-Ser288 (with modifications) |
R&D Systems™ Recombinant Human IL-6 Protein
A New rh IL-6 is Available! The new protein has ∼2 fold better activity and is HEK293 expressed!
| Purity or Quality Grade | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. theroretical: 20.9 kDa |
| Gene Symbol | IL6 |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-6 |
| Source | E. coli-derived human IL-6 protein Pro29-Met212 |
| Name | IL-6 |
| Accession Number | Q75MH2 |
| Gene Alias | B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL6, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6, MGI-2A |
| Gene ID (Entrez) | 3569 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS and NaCl. |
| Recombinant | Recombinant |
| Accession Number | NP_001165097.1 |
|---|---|
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Gene Alias | MVCD1, VAS, vascular endothelial growth factor A, Vascular permeability factor, Vasculotropin, VEGFA, VEGF-A, VEGFMGC70609, VPF, VPFvascular endothelial growth factor |
| Molecular Weight (g/mol) | M.W. Observed: 19-21 kDa, under reducing conditions., M.W. Theoretical: 19.2 kDa (monomer) |
| Gene ID (Entrez) | 7422 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate. |
| Reconstitution | Reconstitute the 10 μg size at 100 μg/mL in sterile deionized water. Reconstitute all other sizes at 500 μg/mL in sterile deionized water. |
| For Use With (Application) | Bioactivity |
| Protein | VEGF |
R&D Systems™ Recombinant Human IFN-gamma Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 16.9 kDa |
| Gene ID (Entrez) | 3458 |
| Quantity | 100 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | E. coli-derived human IFN-gamma protein Gln24-Gln166 with an N-terminal Met |
| Recombinant | Recombinant |
| Name | IFN-gamma |
| Accession Number | P60568.1 |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Gene Alias | aldesleukin, IL2, IL-2 lymphokine, interleukin 2, interleukin-2, involved in regulation of T-cell clonal expansion, T cell growth factor, T-cell growth factor, TCGF |
| Molecular Weight (g/mol) | M.W.-observed: 14-18 kDa, under reducing conditions, M.W.-theoretical: 15 kDa |
| Gene ID (Entrez) | 3558 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA. |
| Reconstitution | Reconstitute at 100-500 μg/mL in sterile 100 mM Acetic Acid |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-2 |
| Source | Chinese Hamster Ovary cell line, CHO-derived human IL-2 protein Ala21-Thr153 |
R&D Systems™ Recombinant Human PDGF-BB Biotinylated Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human TGF-beta 1 (Human Cell-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Buffer | Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. *1 mg pack size (01M) is supplied as a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Conjugate | Unconjugated |
| Specific Reactivity | TGF-beta 1 |
| Molecular Weight (g/mol) | 12.8 kDa (monomer) |
| Gene Symbol | TGFB1 |
| Endotoxin Concentration | <0.01 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Source | Human embryonic kidney cell,HEK293-derived human TGF-beta 1 protein Ala279-Ser390 |
| Accession Number | P01137 |
| Regulatory Status | RUO |
| Gene Alias | CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1 |
| Gene ID (Entrez) | 7040 |
| Reconstitution | Reconstitute at 100 μg/mL in sterile 4 mM HCl containing at least 0.1% human or bovine serum albumin. |
| Species | Human |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Human IL-36 alpha/IL-1F6 Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 17.7 kDa |
| Gene ID (Entrez) | 27179 |
| Quantity | 25 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | E. coli-derived human IL-36 alpha/IL-1F6 protein Met1-Phe158 |
| Recombinant | Recombinant |
| Name | IL-36 alpha/IL-1F6 |
R&D Systems™ Recombinant Human IL-10 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Gene Alias | IL23, IL-23, IL-23 p19/IL-12 p40, IL-23 A, IL-23-A, IL-23p19, IL-23p19/IL-12p40, IL23P19P19, interleukin 23 p19 subunit, interleukin 23, alpha subunit p19, interleukin-23 subunit alpha, Interleukin-23 subunit p19, JKA3 induced upon T-cell activation, MGC79388, SGRF, SGRFIL-23 subunit alpha |
| Molecular Weight (g/mol) | MolecularWeight-observed: 59-68 kDa, 46-52 kDa & 28-33 kDa, under reducing conditions., MolecularWeight-theroretical: 55 kDa (IL-23 single chain), 37 kDa (p40) & 19 kDa (p19) |
| Gene ID (Entrez) | 51561 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Reconstitution | Reconstitute 10 μg size at 100 μg/mL in PBS. Reconstitute all the other sizes (at 500 μg/mL in PBS.) |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-23 A/IL-23 P19 |
| Source | Chinese Hamster Ovary cell line, CHO-derived human IL-23 protein Human IL-23 p40 (Ile23-Ser328) Accession # P29460.1 GSGSSRGGSGSGGSGGGGSKL Human IL-23 p19 (Arg20-Pro189) Accession # AAG37232.1 (C-terminus) |
R&D Systems™ Recombinant Human IL-2 R beta Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | Observed Molecular Wt: 29kDa and 31kDa, reducing conditions, Predicted Molecular Wt.: 25kDa |
| Gene ID (Entrez) | 3560 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Spodoptera frugiperda,Sf 21 (baculovirus)-derived human IL-2 R beta protein Ala27-Asp239 |
| Recombinant | Recombinant |
| Name | IL-2 R beta |
R&D Systems™ Recombinant Human IL-36 beta/IL-1F8 Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
| Purity or Quality Grade | 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 17.7 kDa |
| Gene ID (Entrez) | 27177 |
| Quantity | 25 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | E. coli-derived human IL-36 beta/IL-1F8 protein Met1-Glu157 |
| Recombinant | Recombinant |
| Name | IL-36 beta/IL-1F8 |